Aionx Antimicrobial Technologies
Hershey, US · Pennsylvania corporation
Founders & leadership
SR
Seth R. ZimmermanNamed on SEC filing
RM
Ryan McCombieNamed on SEC filing
JC
Jon C. ZimmermanNamed on SEC filing
GJ
Gary J. ShopeNamed on SEC filing
JH
James HartNamed on SEC filing
TA
Thomas A. FullerNamed on SEC filing
GP
Gautam PatelNamed on SEC filing
Board
GM
Gregory M. BaileyBoard director
WS
Wayne SebastianelliBoard director
TJ
Terry J. MargolisBoard director
RA
Richard A. WyskBoard director
RC
Robert C. VoigtBoard director
Reported raises · per SEC filings
Form D private placements$5.6M disclosed across 4 rounds · 2013–2022
▶$101.2KraisedJul 2022 · 5 investors · BiotechnologyRule 506(b)
▶$101.2KraisedJul 2022 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gary J. ShopeExecutive Officer, Director, Promoter
- Jon C. ZimmermanDirector
- Seth R. ZimmermanExecutive Officer
- Gautam PatelDirector
- James HartDirector
- Offering amount
- $2.5M
- Amount sold
- $101.2K
- First sale
- Jun 2022
- Incorporated
- Corporation, Pennsylvania
- Federal exemptions
- 06b
▶$1.1MraisedMar 2022 · 17 investors · BiotechnologyRule 506(b)
▶$1.1MraisedMar 2022 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jon C. ZimmermanDirector
- Seth R. ZimmermanExecutive Officer
- Thomas A. FullerPromoter
- Ryan McCombieDirector
- Gautam PatelDirector
- Timothy BreyaExecutive Officer
- Gary J. ShopeExecutive Officer, Director, Promoter
- James HartDirector
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- First sale
- Dec 2019
- Incorporated
- Corporation, Pennsylvania
- Federal exemptions
- 06b
▶$3.8MraisedFeb 2019 · 25 investors · BiotechnologyRule 506(b)
▶$3.8MraisedFeb 2019 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Seth R. ZimmermanExecutive Officer
- Ryan McCombieDirector
- Jon C. ZimmermanDirector
- Gary J. ShopeExecutive Officer, Director, Promoter
- James HartDirector
- Thomas A. FullerExecutive Officer, Promoter
- Gautam PatelDirector
- Offering amount
- $7M
- Amount sold
- $3.8M
- First sale
- Aug 2016
- Incorporated
- Corporation, Pennsylvania
- Federal exemptions
- 06b
▶$494.9KraisedJun 2014 · 13 investors · Other TechnologyRule 506(b)
▶$494.9KraisedJun 2014 · 13 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Wayne SebastianelliDirector
- Jon ZimmermanExecutive Officer, Director
- Seth R. ZimmermanExecutive Officer, Director
- Terry J. MargolisDirector
- Richard A. WyskDirector
- Robert C. VoigtDirector
- Paul H. CohenDirector
- Thomas A. FullerExecutive Officer, Director
- Gregory M. BaileyDirector
- Offering amount
- $750K
- Amount sold
- $494.9K
- Minimum investment
- $3.6K
- Proceeds to insiders
- $272K
- First sale
- Jan 2013
- Incorporated
- Corporation, Pennsylvania
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Aionx Antimicrobial Technologies raised?
- Aionx Antimicrobial Technologies has disclosed $5.6M raised across 4 rounds.
- Where is Aionx Antimicrobial Technologies headquartered?
- Aionx Antimicrobial Technologies is headquartered in Hershey, US.